Evidence map›Paper›PMID 28120938›Full record

ArticleScientific reports2017

S-acylation of SOD1, CCS, and a stable SOD1-CCS heterodimer in human spinal cords from ALS and non-ALS subjects.

Sarah E Antinone, Ghanashyam D Ghadge, Lyle W Ostrow, Raymond P Roos, William N Green

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Structural insights into the role of reduced cysteine residues in SOD1 amyloid filament formation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  5. Review
  6. Antioxidants (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sarah E AntinoneUniversity of Chicago, Department of Neurobiology, Chicago, 60637, USA.
Ghanashyam D GhadgeUniversity of Chicago, Department of Neurology, Chicago, 60637, USA.
Lyle W OstrowJohns Hopkins University, Department of Neurology, Baltimore, 21205, USA.
Raymond P RoosUniversity of Chicago, Department of Neurology, Chicago, 60637, USA.
William N GreenUniversity of Chicago, Department of Neurobiology, Chicago, 60637, USA.
University of Chicago · USJohns Hopkins University · US

Funding

Different components of nicotine-induced upregulation of nicotinic receptors - E. Hunpatin SupplementR01DA035430 · NIDA · UNIVERSITY OF CHICAGO · PI GREEN, WILLIAM · 2013 to 2017
$2.3M
Regulation of chloride homeostasis and inhibitory synapses by palmitoylationF32NS077609 · NINDS · UNIVERSITY OF CHICAGO · PI ANTINONE, SARAH ELIZABETH · 2012 to 2014
$163k
NIDA NIH HHS R01 DA035430NINDS NIH HHS F32 NS077609
6 · The paper itself

Abstract

Previously, we found that human Cu, Zn-superoxide dismutase (SOD1) is S-acylated (palmitoylated) in vitro and in amyotrophic lateral sclerosis (ALS) mouse models, and that S-acylation increased for ALS-causing SOD1 mutants relative to wild type. Here, we use the acyl resin-assisted capture (acyl-RAC) assay to demonstrate S-acylation of SOD1 in human post-mortem spinal cord homogenates from ALS and non-ALS subjects. Acyl-RAC further revealed that endogenous copper chaperone for SOD1 (CCS) is S-acylated in both human and mouse spinal cords, and in vitro in HEK293 cells. SOD1 and CCS formed a highly stable heterodimer in human spinal cord homogenates that was resistant to dissociation by boiling, denaturants, or reducing agents and was not observed in vitro unless both SOD1 and CCS were overexpressed. Cysteine mutations that attenuate SOD1 maturation prevented the SOD1-CCS heterodimer formation. The degree of S-acylation was highest for SOD1-CCS heterodimers, intermediate for CCS monomers, and lowest for SOD1 monomers. Given that S-acylation facilitates anchoring of soluble proteins to cell membranes, our findings suggest that S-acylation and membrane localization may play an important role in CCS-mediated SOD1 maturation. Furthermore, the highly stable S-acylated SOD1-CCS heterodimer may serve as a long-lived maturation intermediate in human spinal cord.

Indexed as

Protein MultimerizationProtein Processing, Post-TranslationalAcylationAmyotrophic Lateral SclerosisAnimalsCase-Control StudiesHEK293 CellsHumansMiceMolecular ChaperonesMutationProtein BindingProtein StabilitySpinal CordSuperoxide Dismutase-1CCS protein, humanMolecular ChaperonesSOD1 protein, humanSuperoxide Dismutase-1

Identifiers

PMID28120938
PMCPMC5264640
OpenAlexW2580545098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.